Correlation Between Sinphar Pharmaceutical and Abnova Taiwan

Can any of the company-specific risk be diversified away by investing in both Sinphar Pharmaceutical and Abnova Taiwan at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Sinphar Pharmaceutical and Abnova Taiwan into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Sinphar Pharmaceutical Co and Abnova Taiwan Corp, you can compare the effects of market volatilities on Sinphar Pharmaceutical and Abnova Taiwan and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Sinphar Pharmaceutical with a short position of Abnova Taiwan. Check out your portfolio center. Please also check ongoing floating volatility patterns of Sinphar Pharmaceutical and Abnova Taiwan.

Diversification Opportunities for Sinphar Pharmaceutical and Abnova Taiwan

0.65

Correlation Coefficient

Sinphar Pharmaceutical  Abnova Taiwan

Poor diversification

The 3 months correlation between Sinphar and Abnova is 0.65. Overlapping area represents the amount of risk that can be diversified away by holding Sinphar Pharmaceutical Co and Abnova Taiwan Corp in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Abnova Taiwan Corp and Sinphar Pharmaceutical is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Sinphar Pharmaceutical Co are associated (or correlated) with Abnova Taiwan. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Abnova Taiwan Corp has no effect on the direction of Sinphar Pharmaceutical i.e., Sinphar Pharmaceutical and Abnova Taiwan go up and down completely randomly.

Pair Corralation between Sinphar Pharmaceutical and Abnova Taiwan

Assuming the 90 days trading horizon Sinphar Pharmaceutical Co is expected to generate 0.39 times more return on investment than Abnova Taiwan. However, Sinphar Pharmaceutical Co is 2.58 times less risky than Abnova Taiwan. It trades about 0.09 of its potential returns per unit of risk. Abnova Taiwan Corp is currently generating about -0.03 per unit of risk. If you would invest  3,080  in Sinphar Pharmaceutical Co on December 30, 2024 and sell it today you would earn a total of  90.00  from holding Sinphar Pharmaceutical Co or generate 2.92% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Significant
Accuracy	100.0%
Values	Daily Returns

Sinphar Pharmaceutical Co  vs.  Abnova Taiwan Corp

Sinphar Pharmaceutical

Risk-Adjusted Performance

Modest

Compared to the overall equity markets, risk-adjusted returns on investments in Sinphar Pharmaceutical Co are ranked lower than 6 (%) of all global equities and portfolios over the last 90 days. In spite of fairly stable basic indicators, Sinphar Pharmaceutical is not utilizing all of its potentials. The latest stock price fuss, may contribute to near-short-term losses for the sophisticated investors.

Abnova Taiwan Corp

Risk-Adjusted Performance

Very Weak

Over the last 90 days Abnova Taiwan Corp has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of fairly stable basic indicators, Abnova Taiwan is not utilizing all of its potentials. The latest stock price fuss, may contribute to near-short-term losses for the sophisticated investors.

Pair Trading with Sinphar Pharmaceutical and Abnova Taiwan

The main advantage of trading using opposite Sinphar Pharmaceutical and Abnova Taiwan positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Sinphar Pharmaceutical position performs unexpectedly, Abnova Taiwan can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Abnova Taiwan will offset losses from the drop in Abnova Taiwan's long position.

The idea behind Sinphar Pharmaceutical Co and Abnova Taiwan Corp pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Correlation Analysis module to reduce portfolio risk simply by holding instruments which are not perfectly correlated.